Reach Us +44-1647-403003
Can Mesenchymal Stem Cells Be Used As A Future Weapon Against Breast Cancer? | 54550
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Can mesenchymal stem cells be used as a future weapon against breast cancer?

5th International Conference on Cancer Genomics

Hend Abdel Gawad Shakshouk

Alexandria Faculty of Medicine, Egypt

ScientificTracks Abstracts: J Cancer Sci Ther

DOI: 10.4172/1948-5956.C1.075

Background: Mesenchymal stem cells (MSCs) are recruited to the stroma of cancers. They interact with cancer cells to promote invasion and metastasis or to suppress tumor growth. The unique tumor-homing capacity of MSCs makes them a promising vehicle to deliver various anticancer agents. Aim: The aim of this study was to detect the possibility of using mesenchymal stem cells as a future weapon against breast cancer. Methods: PubMed, PubMed central, Springer and Cochrane databases were searched using specified terms. Results: Literature search yielded 17 manuscripts; seven of which suggested the use of MSCs in breast cancer therapy, while six studies raised the possibility that MSCs may promote tumor growth and four other studies assumed a dual role for MSCs. Conclusions: The role of MSCs in breast cancer therapy is still debatable. We recommend future research in the field of MSCs in Alexandria University as it is our hope in the fight against breast cancer.

Hend Abdel Gawad Shakshouk is currently an Intern at the Faculty of Medicine, Alexandria University, Egypt. She has earned her MBBCh degree and realized her passion for stem cells and regenerative medicine. She wrote her first article review about stem cells and breast cancer which has been accepted for publication. She has joined the Stem Cell Research Team at the Faculty of Medicine, Alexandria University, Egypt.

Email: [email protected]

Relevant Topics